ialuril® Soft Gels

Food supplements

A food supplement supporting the integrity of the glycosaminoglycan layers essential for maintaining normal urinary function

Ialuril Soft Gels box by IBSA - Food supplement containing curcumin, quercetin, hyaluronic acid and chondroitin sulfate

Product description

ialuril® Soft Gels is a food supplement formulated with four key active ingredients: hyaluronic acid (HA), chondroitin sulfate (CS), turmeric extract, and quercetin. These ingredients work together to support urinary tract health and cellular protection.

 

Hyaluronic acid and chondroitin sulfate are naturally present in the bladder and other tissues, helping maintain their structural integrity and normal function. The formulation also includes turmeric extract and quercetin for their antioxidant properties, which help protect cells from oxidative damage. The product is gluten-free and lactose-free, making it suitable for most dietary needs.

Highlights

Urinary tract tissue integrity

Hyaluronic acid and chondroitin sulfate help replenish a defective GAG layer, supporting urinary tract tissue integrity and normal function1,2.

Contains Quercetin

Quercetin is a natural substance found in food, recognized for its antioxidant, anti-inflammatory, and vasodilating properties3.

With Curcumin

Curcumin is the major component of turmeric powder and is known for its anti-inflammatory and antioxidant properties4.

Suitable to various dietary needs

Gluten-free and lactose-free; suitable for diverse dietary needs.

Scientific background*

* Published scientific literature has explored the role of certain nutrients and naturally occurring substances in supporting normal physiological functions of the urogenital tract. These studies provide background information on how such ingredients may contribute to tissue hydration, comfort, and overall intimate wellbeing when used as part of a balanced diet. This information is provided for educational purposes only and does not constitute a medicinal claim.

A well-tolerated food supplement intended to support normal urinary tract function in women5

Studies have explored the use of this ingredient in postmenopausal women, including its role in supporting urinary tract health, particularly when used alongside local oestrogen therapy6

Studies have explored its use in women experiencing menstrual- and pelvic-related discomfort, with observations relating to comfort and symptom experience10

When used alongside ialuril® Prefill, studies have explored potential supportive effects on bladder comfort, including in settings where the bladder may be irritated, such as during radiotherapy7

Studies have examined its use in relation to genitourinary comfort and tolerance, with observations reported in clinical settings8,9

Generally well tolerated when used as a food supplement in adults, including in settings where the bladder may be exposed to irritation associated with medical treatments11

Studies have explored its use in men experiencing prostate-related discomfort, with observations relating to urinary comfort and symptom perception over a short-term period12

Contact IBSA
Back to the ialuril® product line

ialuril® product line

ialuril® Prefill

Medical device

Ialuril Prefill box by IBSA - Sterile solution containing sodium hyaluronate, chondroitin sulphate, and calcium chloride for intravesical instillation
Discover the details

Section reserved for healthcare professionals

This section contains information intended for healthcare professionals. By continuing, you confirm that you are a healthcare professional authorized to access this content.

Are you a healthcare professional (HCP)?

No, go back

References

  • 1 / ialuril soft gels – product profile.
  • 2 / ialuril soft gels - information leaflet.
  • 3 / Chen C, et al. Life Sciences. 2010; 87(11-12): 333-338.
  • 4 / Menon VP, et al. Adv Exp Med Biol. 2007; 595: 105-25.
  • 5 / Schiavi MC et al. Female Pelvic Med Reconstr Surg. 2019;25(4):309-312.
  • 6 / Torella M et al. Eur J Obstet Gynecol Reprod Biol. 2016;207:125-128.
  • 7 / Redorta JP et al. Eur Urol Open Sci. 2021;26:45-54.
  • 8 / Fersino S et al. Minerva Urol Nefrol. 2016;68(1):9-13.
  • 9 / Nicosia L, et al. Cancer Manag Res. 2022 Sep 20;14:2839-2846.
  • 10 / Zupi E et al. Journal of Endometriosis and Pelvic Pain Disorders 2015.
  • 11 / Manfredi C, et al. Pathophysiology. 2022 Jul 13;29(3):365-373.
  • 12 / Iacovelli V, et al. Frontiers in Surgery 2025. DOI 10.3389/fsurg.2025.1700681